Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis

被引：38
作者：
Cao, Yajuan [1 ]
Zhu, Weikang [1 ]
Chen, Wanqing [1 ]
Wu, Jianchun [1 ]
Hou, Guozhen [1 ]
Li, Yan [1 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai 200071, Peoples R China
来源：
DISEASE MARKERS | 2019年 / 2019卷
关键词：
SURVIVIN;
D O I：
10.1155/2019/5451290
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Objective. This study was aimed at investigating the prognostic significance of Baculoviral IAP repeat containing 5 (BIRC5) in lung adenocarcinoma (LAD) lacking EGFR, KRAS, and ALK mutations (triple-negative (TN) adenocarcinomas). Methods. The gene expression profiles were obtained from Gene Expression Omnibus (GEO). The identification of the differentially expressed genes (DEGs) was performed by GeneSpring GX. Gene set enrichment analysis (GSEA) was used to execute gene ontology function and pathway enrichment analysis. The protein interaction network was constructed by Cytoscape. The hub genes were extracted by MCODE and cytoHubba plugin from the network. Then, using BIRC5 as a candidate, the prognostic value in LAD and TN adenocarcinomas was verified by the Kaplan-Meier plotter and The Cancer Genome Atlas (TCGA) database, respectively. Finally, the mechanism of BIRC5 was predicted by a coexpressed network and enrichment analysis. Results. A total of 38 upregulated genes and 121 downregulated genes were identified. 9 hub genes were extracted. Among them, the mRNA expression of 5 genes, namely, BIRC5, MCM4, CDC20, KIAA0101, and TRIP13, were significantly upregulated among TN adenocarcinomas (all P<0.05). Notably, only the overexpression of BIRC5 was associated with unfavorable overall survival (OS) in TN adenocarcinomas (log rank P=0.0037). TN adenocarcinoma patients in the BIRC5 high-expression group suffered from a significantly high risk of distant metastasis (P=0.046), advanced N stage (P=0.033), and tumor-bearing (P=0.031) and deceased status (P=0.003). The mechanism of BIRC5 and coexpressed genes may be linked closely with the cell cycle. Conclusion. Overexpressed in tumors, BIRC5 is associated with unfavorable overall survival in TN adenocarcinomas. BIRC5 is a potential predictor and therapeutic target in TN adenocarcinomas.
引用
收藏
页数：12
相关论文
共 41 条
[1]   Survivin, versatile modulation of cell division and apoptosis in cancer [J].
Altieri, DC .
ONCOGENE, 2003, 22 (53) :8581-8589
[2]   Gene network analysis reveals the association of important functional partners involved in antibiotic resistance: A report on an important pathogenic bacterium Staphylococcus aureus [J].
Anitha, P. ;
Anbarasu, Anand ;
Ramaiah, Sudha .
GENE, 2016, 575 (02) :253-263
[3]   Cancer Bioinformatic Methods to Infer Meaningful Data From Small-Size Cohorts [J].
Bennani-Baiti, Abila ;
Bennani-Baiti, Idriss M. .
CANCER INFORMATICS, 2015, 14 :131-139
[4]   Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer [J].
Camidge, D. R. ;
Kim, H. R. ;
Ahn, M. -J. ;
Yang, J. C. -H. ;
Han, J. -Y. ;
Lee, J. -S. ;
Hochmair, M. J. ;
Li, J. Y. -C. ;
Chang, G. -C. ;
Lee, K. H. ;
Gridelli, C. ;
Delmonte, A. ;
Garcia Campelo, R. ;
Kim, D. -W. ;
Bearz, A. ;
Griesinger, F. ;
Morabito, A. ;
Felip, E. ;
Califano, R. ;
Ghosh, S. ;
Spira, A. ;
Gettinger, S. N. ;
Tiseo, M. ;
Gupta, N. ;
Haney, J. ;
Kerstein, D. ;
Popat, S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (21) :2027-2039
[5]   The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data [J].
Cerami, Ethan ;
Gao, Jianjiong ;
Dogrusoz, Ugur ;
Gross, Benjamin E. ;
Sumer, Selcuk Onur ;
Aksoy, Buelent Arman ;
Jacobsen, Anders ;
Byrne, Caitlin J. ;
Heuer, Michael L. ;
Larsson, Erik ;
Antipin, Yevgeniy ;
Reva, Boris ;
Goldberg, Arthur P. ;
Sander, Chris ;
Schultz, Nikolaus .
CANCER DISCOVERY, 2012, 2 (05) :401-404
[6]   cytoHubba: identifying hub objects and sub-networks from complex interactome [J].
Chin, Chia-Hao ;
Chen, Shu-Hwa ;
Wu, Hsin-Hung ;
Ho, Chin-Wen ;
Ko, Ming-Tat ;
Lin, Chung-Yen .
BMC SYSTEMS BIOLOGY, 2014, 8
[7]   Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers [J].
Dogan, Snjezana ;
Shen, Ronglai ;
Ang, Daphne C. ;
Johnson, Melissa L. ;
D'Angelo, Sandra P. ;
Paik, Paul K. ;
Brzostowski, Edyta B. ;
Riely, Gregory J. ;
Kris, Mark G. ;
Zakowski, Maureen F. ;
Ladanyi, Marc .
CLINICAL CANCER RESEARCH, 2012, 18 (22) :6169-6177
[8]   Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis [J].
Duan, Liang ;
Hu, Xuefei ;
Jin, Yuxing ;
Liu, Ruijun ;
You, Qingjun .
BMC CANCER, 2016, 16
[9]   ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer [J].
Gainor, Justin F. ;
Varghese, Anna M. ;
Ou, Sai-Hong Ignatius ;
Kabraji, Sheheryar ;
Awad, Mark M. ;
Katayama, Ryohei ;
Pawlak, Amanda ;
Mino-Kenudson, Mari ;
Yeap, Beow Y. ;
Riely, Gregory J. ;
Iafrate, A. John ;
Arcila, Maria E. ;
Ladanyi, Marc ;
Engelman, Jeffrey A. ;
Dias-Santagata, Dora ;
Shaw, Alice T. .
CLINICAL CANCER RESEARCH, 2013, 19 (15) :4273-4281
[10]   Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal [J].
Gao, Jianjiong ;
Aksoy, Buelent Arman ;
Dogrusoz, Ugur ;
Dresdner, Gideon ;
Gross, Benjamin ;
Sumer, S. Onur ;
Sun, Yichao ;
Jacobsen, Anders ;
Sinha, Rileen ;
Larsson, Erik ;
Cerami, Ethan ;
Sander, Chris ;
Schultz, Nikolaus .
SCIENCE SIGNALING, 2013, 6 (269) :pl1
12345